By Josh Beckerman
Shares of Surgalign Holdings, which filed for bankruptcy on Monday, were up 29%, to 26 cents, Friday after the company said it would be delisted from Nasdaq.
Trading would be suspended at the opening of business on July 3. After the Nasdaq delisting takes effect, the stock is expected to trade over-the-counter.
The medical technology company said Tuesday it agreed to sell substantially all of its U.S. hardware and biomaterials assets, and equity interests in certain entities, to Xtant Medical Holdings for $5 million.
Surgalign also noted Tuesday that trading in its stock "is highly speculative and poses substantial risks." It said it expected that holders of common shares "could experience a significant or complete loss on their investment."
The stock closed at $1.22 on June 16 and fell 82% Tuesday.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
June 23, 2023 14:04 ET (18:04 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。